Clinical Trial Update: Metabolic Response to Infliximab in Pediatric Ulcerative Colitis [NA]

View source ↗

Summary

A pediatric ulcerative colitis trial assessing metabolic response to infliximab was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Indiana University | Conditions: Ulcerative Colitis, Protein Metabolism | NA | Status: TERMINATED